Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

NCT01877590 is registered in ClinicalTrials.gov with Wuhan General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT01877590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01877590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
Lead sponsor
Wuhan General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
July 31, 2015
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, left ventricular mass, type 2 diabetes